VivaMed BioPharma

VivaMed BioPharma is a clinical-stage pharmaceutical company that leverages a proprietary AI engine to discover and advance repurposed and novel therapeutic assets. The company focuses on high-impact therapies for urgent health needs, particularly in neurology, pain management, addiction, and rare genetic diseases. By integrating computational drug hypotheses with global validation infrastructure, including a strategic partnership with Syngene International, VivaMed aims to de-risk development and accelerate the path to clinical proof of concept. Their model emphasizes speed and scientific rigor, targeting overlooked drug assets with clear therapeutic potential. The company maintains a global presence with offices in major biotech hubs and collaborates with over 30 academic institutions to identify promising science early.